SCHEMBL8799648

SCHEMBL8799648

CCOC(=O)C(Oc1cccnc1)(C(=O)OCC)C(N)CCC(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CCNC P24863 1/20 0.35
CDK8 P49336 1/20 0.35
GRM2 Q14416 1/20 0.35
TSHR P16473 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TBXAS1 P24557 3/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 2/20 0.33
NPC1 O15118 1/20 0.33
ADA P00813 1/20 0.33
CPB2 Q96IY4 1/20 0.33
CNR1 P21554 1/20 0.33
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
PKM P14618 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8799931 0.87 TSHR (0.36) TSHRNPSR1MAPTCPB2ALDH1A1
SCHEMBL8798766 0.84 CYP3A4 (0.37) MAPK1SMN1; SMN2GRM2TSHRADA
SCHEMBL8798264 0.82 TBXAS1 (0.37) MAPK1SMN1; SMN2TBXAS1ALDH1A1CYP3A4
SCHEMBL8798844 0.77 DPP4 (0.40) MAPK1SMN1; SMN2GRM2TSHRADA
SCHEMBL8799774 0.77 CYP17A1 (0.35) TSHRMAPTALDH1A1PKMKMT2A
SCHEMBL8799646 0.76 MAPK1 (0.37) MAPK1SMN1; SMN2CCNCCDK8GRM2
SCHEMBL8800048 0.76 PGR (0.35) MAPK1SMN1; SMN2TSHRMAPTRAB9A
SCHEMBL8633548 0.75 SLC7A5 (0.40) SMN1; SMN2TSHRNPSR1RAB9ANPC1
SCHEMBL8329548 0.74 LTA4H (0.41) TSHRMAPTALDH1A1KMT2A
SCHEMBL1969926 0.73 PPARA (0.56) MAPK1SMN1; SMN2CCNCCDK8GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed